Prenetics Global (PRE) Non Operating Investment Income (2021 - 2025)

Prenetics Global (PRE) posted quarterly Non Operating Investment Income of $2.0 million for Q4 2025, up 800.03% quarter-over-quarter from -$292132.0 in Q4 2021.

Prenetics Global (PRE) Non Operating Investment Income (2021 - 2025) Analysis & Trends

Prenetics Global (PRE) has reported Non Operating Investment Income for 2 consecutive years, with $2.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Non Operating Investment Income changed N/A year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at -$20.0 million (changed N/A YoY), while the FY2025 annual figure was $2.0 million, changed N/A from the prior year.
  • Non Operating Investment Income advanced to $2.0 million in Q4 2025 per PRE's latest filing, from -$292132.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $2.0 million in Q4 2025 and bottomed at -$21.8 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 213.44 Bn 209.37 Bn 8.34 Bn -
2 Danaher 139.95 Bn 135.60 Bn 3.61 Bn -
3 Idexx Laboratories 46.16 Bn 45.96 Bn 779.09 Mn -
4 Agilent Technologies 39.67 Bn 37.87 Bn 990.00 Mn -
5 Iqvia Holdings 39.29 Bn 37.21 Bn 1.44 Bn -
6 Natera 38.61 Bn 37.51 Bn 696.04 Mn -
7 Illumina 29.99 Bn 28.82 Bn 770.00 Mn -
8 Mettler Toledo International 28.57 Bn 28.51 Bn 650.22 Mn -
9 Quest Diagnostics 26.17 Bn 25.55 Bn 1.03 Bn -
10 Prenetics Global 308.40 Mn 202.37 Mn 23.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.05 Mn
Dec 31, 2025 2.05 Mn
Dec 31, 2021 -292,132.00
Dec 31, 2021 -292,132.00
Jun 30, 2021 -21.79 Mn
Jun 30, 2021 -21.79 Mn
Mar 31, 2021 -7.27 Mn
Mar 31, 2021 -7.27 Mn